Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer
about
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studiesPolymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white womenPotential role of chitinase 3-like-1 in inflammation-associated carcinogenic changes of epithelial cellsTargeted immune therapy of ovarian cancerHistory of hypertension, heart disease, and diabetes and ovarian cancer patient survival: evidence from the ovarian cancer association consortium.Cigarette smoking is associated with adverse survival among women with ovarian cancer: Results from a pooled analysis of 19 studies.Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association ConsortiumChronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association ConsortiumAssociation between Body Powder Use and Ovarian Cancer: The African American Cancer Epidemiology Study (AACES)Assessment of Multifactor Gene-Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors.Analgesic medication use and risk of epithelial ovarian cancer in African American women.Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium studyRisk factors for epithelial ovarian cancer by histologic subtype.Nonsteroidal anti-inflammatory drugs and risk for ovarian and endometrial cancers in the Iowa Women's Health StudyThe potential role of infectious agents and pelvic inflammatory disease in ovarian carcinogenesisUtilization of gene profiling and proteomics to determine mineral pathogenicity in a human mesothelial cell line (LP9/TERT-1).Polymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the ovarian cancer association consortium.Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models.Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium.Estimated intake of dietary phyto-oestrogens in Australian women and evaluation of correlates of phyto-oestrogen intake.Mumps and ovarian cancer: modern interpretation of an historic association.Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies.Markers of inflammation and risk of ovarian cancer in Los Angeles CountyRecent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium.An increased risk of epithelial ovarian cancer in Taiwanese women with a new surgico-pathological diagnosis of endometriosisA case-control study of glycemic index, glycemic load and dietary fiber intake and risk of adenocarcinomas and squamous cell carcinomas of the esophagus: the Australian Cancer StudyThe Association Between Talc Use and Ovarian Cancer: A Retrospective Case-Control Study in Two US States.Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study.Interaction between use of non-steroidal anti-inflammatory drugs and selected genetic polymorphisms in ovarian cancer riskOvarian epithelial-stromal interactions: role of interleukins 1 and 6.Endometriosis: a high-risk population for major chronic diseases?Menstrual pain and epithelial ovarian cancer riskMutational landscape of mucinous ovarian carcinoma and its neoplastic precursors.Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium.Genital powder exposure and the risk of epithelial ovarian cancerBRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.Cancers in Australia in 2010 attributable to and prevented by the use of menopausal hormone therapy.Use of nonsteroidal anti-inflammatory drugs and risk of ovarian and endometrial cancer: the Multiethnic Cohort.Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancerNon-steroidal anti-inflammatory drug use and ovarian cancer risk: findings from the NIH-AARP Diet and Health Study and systematic review.
P2860
Q24619808-3C5C17AF-8B44-43FE-BEEC-D9EEB96D0F03Q24648412-FAD53ABD-DD23-4471-97C3-DED49306453BQ24656942-FDD822AC-DEC5-445D-8AD9-737F4B3478E0Q28082828-3C360541-7B7E-46FA-983E-72F19624B768Q30252952-A1AC6D77-0B34-4E20-AB4B-542A5A5FCB7DQ30275068-8C2BF47C-CD01-43DC-B2B7-5C850F0FD898Q30276610-B283C263-951F-4C6B-9910-C35573A17A0FQ30276777-4B55E168-2205-4B42-B662-8AB358675D78Q30276778-CCE01945-4F5A-4B67-80E6-63A3118321C2Q30277151-95F85FB5-D6E9-4208-9150-9591AFA12EC6Q30277284-DE779FD3-A10E-4B9A-9F47-16A613093131Q33551425-E9B58DEC-9959-4532-BEEA-313EC39D0FD7Q33552610-42887605-2B9F-466E-8409-7ECD3072D329Q33645700-09AE8122-9854-4C04-82B0-04534AF9201EQ33705880-13E0D93F-CF66-4B88-B876-B77ABA4271D9Q33727096-3B6B87E7-93CE-408A-85E8-740E17B10BA1Q33747831-12FF7079-3725-44AA-BA1B-F4344E62D0CAQ33886458-9D6D862E-CBCF-4A70-875B-B06082EBFC3DQ33921008-E3485FD7-1A10-4CD5-ADAA-A794946030D2Q34127131-BEE46A29-EDE2-4D63-B3EC-CFFF419CA2DAQ34180646-8A76CDF2-ACDC-4665-9E33-1395CB22227CQ34338047-033FAC93-E867-4197-81BE-01B007FA02A7Q34372351-BA5FC5B9-0267-4B30-A4DC-2A264CD64281Q34557167-5144EBD0-8055-499B-AA33-856B64E2C13EQ34558361-9EDD519B-A3E0-46A3-943E-CD0228C4BD0CQ34632561-4BCCD317-92D9-46D4-BD1A-B06491C88F5BQ34674926-0A1167EB-93A1-4082-8199-7565CDE2E34DQ34687073-259E5ED8-CDC6-4341-895D-2DAA9F886DE7Q34794017-6FB08333-D8E4-419D-8581-9328E39F5CA3Q35101318-0B7B3D3B-9F6F-43C7-B7DE-13054BCBAD3BQ35718207-3A49BB3C-AAA9-4F92-A0C2-F25C25DCD5A6Q35845474-AD72EB8E-0D2A-4225-8285-EAB0E5FF1083Q35926362-691B189E-30FA-49CC-8F2B-B31B039DE7CEQ36027025-1086D0B3-4E5D-4244-922E-243A0D04EC68Q36062556-72C58EEF-EA06-4BB1-95CD-ADE6DC5F524DQ36145443-EE82A043-48B0-46DC-97DE-E671CFBCF062Q36164444-265211B7-B83B-420D-86B1-EF32AB978D70Q36218488-3470D85B-A70E-44AE-8C0D-C629C8E0ABD7Q36266504-1232F4BA-31F6-43AE-8413-151EDBC5771BQ36313004-F22D2843-A863-41EB-8ABF-48B66F4E4AC5
P2860
Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Talcum powder, chronic pelvic ...... k of epithelial ovarian cancer
@ast
Talcum powder, chronic pelvic ...... k of epithelial ovarian cancer
@en
Talcum powder, chronic pelvic ...... k of epithelial ovarian cancer
@nl
type
label
Talcum powder, chronic pelvic ...... k of epithelial ovarian cancer
@ast
Talcum powder, chronic pelvic ...... k of epithelial ovarian cancer
@en
Talcum powder, chronic pelvic ...... k of epithelial ovarian cancer
@nl
prefLabel
Talcum powder, chronic pelvic ...... k of epithelial ovarian cancer
@ast
Talcum powder, chronic pelvic ...... k of epithelial ovarian cancer
@en
Talcum powder, chronic pelvic ...... k of epithelial ovarian cancer
@nl
P2093
P3181
P356
P1476
Talcum powder, chronic pelvic ...... k of epithelial ovarian cancer
@en
P2093
Adèle C Green
Christina M Nagle
Melissa A Merritt
P3181
P356
10.1002/IJC.23017
P407
P577
2008-01-01T00:00:00Z